Long-term immunological benefit in patients with discordant responses to therapy depends on both level of viremia and duration of rebound.
Lina
L
Tomasoni
Andrea
A
Patroni
Maria Cristina
MC
Uccelli
Francesco
F
Gargiulo
Carlo
C
Torti
Giampiero
G
Carosi
Francesco
F
Castelli
D023241:Antiretroviral Therapy, Highly Active; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000821:virology; D015331:Cohort Studies; D006678:HIV / Q000254:growth & development / Q000276:immunology* / Q000378:metabolism; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006801:Humans; D007558:Italy; D008137:Longitudinal Studies; D012367:RNA, Viral / Q000097:blood; D014766:Viremia / Q000188:drug therapy / Q000276:immunology / Q000821:virology
D012367:RNA, Viral